Using Pharmacogenetics to Find Treatment for Familial Hypercholesterolemia Patients with Both apoB and PCSK9 Mutations
Familial hypercholesterolemias (FH) are inherited mutations that cause elevated total cholesterol and low-density lipoprotein cholesterol levels (LDL-C) which lead to premature coronary heart diseases. Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which ca...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholarship @ Claremont
2019
|
| Subjects: | |
| Online Access: | https://scholarship.claremont.edu/scripps_theses/1229 https://scholarship.claremont.edu/cgi/viewcontent.cgi?article=2377&context=scripps_theses |